Department for Molecular Biomedicine, Centre for Investigation and Advanced Studies of the National Polytechnic Institute (Cinvestav-IPN), 07360 Mexico City, Mexico.
Leukemia Clinic, Children's Hospital of Mexico Federico Gómez, 06720 Mexico City, Mexico.
Blood Rev. 2018 Jan;32(1):36-51. doi: 10.1016/j.blre.2017.08.006. Epub 2017 Aug 15.
T-cell acute lymphoblastic leukemia (T-ALL) accounts for 15% and 25% of total childhood and adult ALL cases, respectively. During T-ALL, patients are at risk of organ infiltration by leukemic T-cells. Infiltration is a major consequence of disease relapse and correlates with poor prognosis. Transendothelial migration of leukemic cells is required to exit the blood stream into target organs. While mechanisms of normal T-cell transmigration are well known, the mechanisms of leukemic T-cell extravasation remain elusive; but involvement of chemokines, integrins and Notch signaling play critical roles. Here, we summarize current knowledge about molecular mechanisms of leukemic T-cell infiltration with special emphasis on the newly identified subtype early T-cell-progenitor (ETP)-ALL. Furthermore, we compare the extravasation potential of T-ALL cells with that of other hematologic malignancies such as B-ALL and acute myeloid leukemia (AML).
T 细胞急性淋巴细胞白血病(T-ALL)分别占儿童和成人 ALL 病例的 15%和 25%。在 T-ALL 中,患者存在白血病 T 细胞浸润器官的风险。浸润是疾病复发的主要后果,与预后不良相关。白血病细胞穿过血管内皮迁移是离开血流进入靶器官所必需的。虽然正常 T 细胞迁移的机制众所周知,但白血病 T 细胞外渗的机制仍不清楚;但是趋化因子、整合素和 Notch 信号转导起着关键作用。在这里,我们总结了白血病 T 细胞浸润的分子机制的最新知识,特别强调了新确定的早期 T 细胞前体(ETP)-ALL 亚型。此外,我们比较了 T-ALL 细胞与其他血液系统恶性肿瘤(如 B-ALL 和急性髓系白血病(AML))的外渗潜力。